• Fri, December 1, 2023
Jessica Fye Downgraded (BNTX) to Sell and Decreased Target to $99 on, Dec 1st, 2023
Jessica Fye of JP Morgan, Downgraded "BioNTech SE" (BNTX) to Sell and Decreased Target from $106 to $99 on, Dec 1st, 2023.
Jessica has made no other calls on BNTX in the last 4 months.
There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Korn of "Morgan Stanley" Maintained at Hold with Increased Target to $111 on, Wednesday, November 8th, 2023
- Yifeng Liu of "HSBC" Downgraded from Strong Buy to Hold and Decreased Target to $111 on, Monday, October 16th, 2023
This is the rating of the analyst that currently disagrees with Jessica
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $133 on, Monday, November 27th, 2023
Like: 👍
